Our team investigates diagnostic and therapeutic applications of epigenetic mechanisms in cancer. We integrate scientific expertise in epigenetics/epigenomics, molecular biology, primary cell culture, proteomics, xenograft models with clinical resources of primary patient samples (i.e. blood, pleural effusions, tumor tissues) to address unmet medical need for patients with lung cancer.